-
Morning Market Movers (DSCM, TSON, CHRS, TLB)
Thursday, March 24, 2011 - 9:44am | 120Drugstore.com Inc (NASDAQ: DSCM) climbed 112.29% to $3.80 at 9:42 am. Walgreen Co (NYSE: WAG) agreed to buy DSCM for around $429 million in cash. TranS1 Inc (NASDAQ: TSON) shares surged 28.22% to $4.18. TSON received Food and Drug Administration (FDA) approval for a spinal implant system....
-
TranS1 Trading Higher Today (TSON)
Thursday, March 24, 2011 - 9:39am | 30TranS1 (NASDAQ: TSON) is trading higher today. At the time of posting, shares of TSON were trading at $4.11, up 26.07% from Wednesday's close.
-
TranS1 Jumps 38%+ On Positive FDA Announcement (TSON)
Thursday, March 24, 2011 - 8:08am | 230TranS1 (NASDAQ: TSON), a pioneer in minimally invasive approaches to lumbar spine surgery, today announced the 510(k) clearance of the AxiaLIF(R) 1L+ product line, an instrumentation and implant system for L5-S1 lumbar fusion. The AxiaLIF 1L+ system represents the next generation of the original...
-
West and CareFusion Announce Plans to Develop a Needle-Free Vented Vial Access Device
Thursday, March 24, 2011 - 8:08am | 57West Pharmaceutical Services, Inc. (NYSE: WST) and CareFusion, (NYSE: CFN) today announced they will jointly develop and market a new, needle-free vial access device. This initiative is part of a five year global distribution and supply agreement between the two companies.
-
Oppenheimer Maintains ELGX Outperform Rating
Thursday, March 24, 2011 - 8:07am | 122Oppenheimer has reiterated an Outperform Rating for Endologix Inc (NASDAQ: ELGX) after attending management meetings. According to Oppenheimer, "After spending time with ELGX management on the road this week, we remain convinced that ELGX has the best product pipeline in AAA and that the new...
-
ViroPharma Announces Cinryzeman Data Presented at 2011 AAAAI Annual Meeting
Tuesday, March 22, 2011 - 10:21am | 113ViroPharma Incorporated (Nasdaq: VPHM) today announced data presented in two poster presentations relating to Cinryze at the 2011 American Academy of Allergy Asthma & Immunology (AAAAI) Annual Meeting, March 18 through 22, in San Francisco, CA. Cinryze is the first and only U.S. FDA-approved...
-
Neogen Reports Q3 EPS of $0.21 vs. $0.21; Revenues $42.24M vs. $39.8M
Tuesday, March 22, 2011 - 8:46am | 102Neogen Corporation (Nasdaq: NEOG) announced today that its net income for the third quarter of FY 2011, which ended Feb. 28, increased 27% from the previous year to $4,943,000 — or to $0.21 per share, compared to the prior year's $0.17 per share. Third quarter revenues increased 25% to $42,235,...
-
Earnings Scheduled For March 22 (ADBE, CTAS, WAG, DFS, CCL, JBL, DG, GIII, SONC, CMC, FSII, WNI, NEOG, HWD)
Tuesday, March 22, 2011 - 12:48am | 371Adobe Systems Incorporated (NASDAQ: ADBE) is expected to report its Q1 EPS at $0.57 on revenue of $1.03 billion. Cintas Corporation (NASDAQ: CTAS) is estimated to report its Q3 EPS at $0.36 on revenue of $907.56 million. Walgreen Company (NYSE: WAG) is projected to report its Q2 EPS at $0.80 on...
-
A Peek Into The Market Before The Trading Starts
Monday, March 21, 2011 - 7:36am | 420Pre-open movers US stock futures are higher this morning, after AT&T (NYSE: T) announced its plans to buy T-Mobile USA for around $39 billion. Futures for the Dow Jones Industrial Average surged 105 points to 11,904.00, while those for the S&P 500 stock index climbed 13.60 points to 1,287....
-
FDA Assigns PDUFA Date for Shire's FIRAZYR for the Treatment of Acute Attacks of Hereditary Angioedema
Monday, March 21, 2011 - 7:17am | 155Shire plc (NASDAQ: SHPGY) today announced that the US Food and Drug Administration (FDA) has assigned a Prescription Drug User Fee Act (PDUFA) date of August 25, 2011 for the review of the New Drug Application (NDA) for FIRAZYR(R) (icatibant) for the treatment of acute attacks (Types I and II) of...
-
Utah Medical Products, Inc. Acquires Femcare Group Limited
Friday, March 18, 2011 - 12:21pm | 74Utah Medical Products, Inc. (Nasdaq: UTMD) announces it has purchased all of the common shares of Femcare Holdings Limited of the United Kingdom, including its trading subsidiaries, Femcare-Nikomed Ltd. of Southampton, England and Femcare Australia. Femcare is best known for its global brand the...
-
Piper Jaffray Discontinues Coverage on Alcon (ACL)
Thursday, March 17, 2011 - 8:26am | 145Piper Jaffray is out with its report today on Alcon (NYSE: ACL), discontinuing coverage on shares of ACL. In a note to clients, Piper Jaffray writes, "On December 15, 2010, Alcon and Novartis agreed to a merger agreement whereby Novartis will acquire the 23% of Alcon shares it does not currently...
-
Endologix Reports revised Q4 GAAP EPS of $0.22 vs. Previously Announced $0.15
Wednesday, March 16, 2011 - 4:33pm | 178Endologix, Inc. (Nasdaq: ELGX) today announced the filing of its annual report on Form 10-K and certain revisions to its previously reported unaudited fourth quarter and full year 2010 financial results. Upon finalization of the purchase price allocation related to Endologix's December 2010...
-
Morgan Keegan Maintains Outperform Rating, $73 PT On COO
Wednesday, March 16, 2011 - 7:36am | 92Morgan Keegan is maintaining its Outperform rating and $73 PT on shares of The Cooper Companies Inc. (NYSE: COO). “Following a 3.7% decline in Cooper shares yesterday due to concerns about the evolving situation in Japan, we have again checked in with management to get an update on the company's...
-
Trading Resumes: DENTSPLY International
Tuesday, March 15, 2011 - 10:05am | 16Trading Resumes: DENTSPLY International (NASDAQ: XRAY)